English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Recently, Hewitt et al. [1] demonstrated transmission of hepatitis E viruses (HEV) via contaminated blood in 42% of transfusion recipients. The authors reported a prevalence rate of 1:2,848 HEV RNA-positive donors in England, a figure comparable to other European countries (Germany 1:1,240 [2], The Netherlands 1:1,761 [3]). In industrial countries, chronic, severe, or fatal HEV infections have been observed in immunosuppressed individuals (e.g. transplant patients, hematological patients [4]) and in individuals with pre-existing liver diseases [5,6].

Knowledge Is Safety: The Time Is Ripe for Hepatitis E Virus Blood Donor Screening